Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Indaptus Therapeutics Inc INDP

Healthcare Biotechnology
Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company, which specializes in cancer and viral infection treatments. The Company’s approach is based on the hypothesis that activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be... see more

Recent & Breaking News (NDAQ:INDP)

Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference

PR Newswire November 8, 2017

Intec Pharma, Ltd. Announces Changes to its Board of Directors

PR Newswire November 1, 2017

Intec Pharma Names Walt Linscott as Chief Administrative Officer

PR Newswire October 26, 2017

Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit

PR Newswire October 6, 2017

Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference

PR Newswire September 20, 2017

Intec Pharma to Participate in the 19th Annual Rodman & Renshaw Global Investment Conference

PR Newswire September 8, 2017

Intec Pharma to Participate in BioCentury's 24th Annual NewsMakers in the Biotech Industry Conference

PR Newswire September 1, 2017

Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares

PR Newswire August 21, 2017

Mid-Afternoon Market Update: Crude Oil Down 1.5%; Phoenix New Media Shares Spike Higher

Benzinga.com  August 16, 2017

12 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  August 16, 2017

Mid-Morning Market Update: Markets Open Higher; Target Profit Tops Expectations

Benzinga.com  August 16, 2017

Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares

PR Newswire August 16, 2017

Intec Pharma Announces Proposed Public Offering of Ordinary Shares

PR Newswire August 15, 2017

Intec Pharma Reports Financial Results for the First Six Months of 2017

PR Newswire August 9, 2017

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

PR Newswire August 3, 2017

Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer

PR Newswire July 27, 2017

Intec Pharma Granted Patent in Hong Kong for Accordion Pill™ Carbidopa / Levodopa

PR Newswire July 19, 2017

Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer

PR Newswire July 10, 2017

Intec Pharma to Participate at Upcoming June Conferences

Business Wire May 31, 2017

Intec Pharma Granted U.S. Patent for Accordion Pill™ Comprising Levodopa for Improved Treatment of Parkinson's Diseases Symptoms

PR Newswire May 24, 2017